Atorvastatin and Omeprazole Drug Interaction Study
Treatments studied
This study tests how two common medications, atorvastatin (a cholesterol-lowering drug) and omeprazole (a stomach acid reducer), interact in your body. It may help doctors understand how to use them together safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 21 and 75 years old, or a woman between 50 and 75 years old.
- You have not taken any statin (like atorvastatin) or proton pump inhibitor (like omeprazole) in the past 30 days.
- You are willing to take atorvastatin and omeprazole once daily and come back for a follow-up after 1 month.
- You do not have liver disease, kidney problems, muscle pain or breakdown issues, or a history of alcohol or drug abuse.
- You are not pregnant, planning to become pregnant, or breastfeeding.
- You are not allergic to atorvastatin, omeprazole, or any similar medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if taking two experimental medicines together is safe and how they interact with each other in healthy volunteers. It tests whether the combination is well-tolerated and helps researchers understand how the body processes them.
This study checks if stomach acid medicine and another drug affect how the body handles a new investigational drug. It helps researchers understand dosing for future patients.
This trial studies whether cholesterol-lowering medicine (a statin, specifically atorvastatin) improves health and benefits in people age 75 and older in everyday life. It may help doctors understand which older adults benefit most and how to use these medicines safely.
This trial tests if a common cholesterol medicine, atorvastatin, can slow the progression of arrhythmogenic cardiomyopathy, a genetic heart condition that can cause abnormal heart rhythms. If you have this condition, joining this study may help researchers find a new way to protect your heart.
This trial tests a combination pill of two cholesterol-lowering medicines (pitavastatin and ezetimibe) in adults who have been taking either atorvastatin or rosuvastatin for at least 3 months. It aims to see if switching to this new combination is safe and effective.
This study compares a new cholesterol medication combination to a standard high-intensity statin in patients aged 75 and older who have had a heart procedure to open blocked arteries. The goal is to see which treatment is better at managing cholesterol and reducing future heart risks.
Hear when a new Metabolite trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.